Areva - Reference Document 2016

20

20.2 Notes to the consolidated financial statements for the year ended December 31, 2016 FINANCIAL INFORMATION CONCERNING ASSETS, FINANCIAL POSITION AND FINANCIAL PERFORMANCE

Share in net income of joint ventures and associates

(in millions of euros)

December 31, 2016 December 31, 2015

Adwen

(14)

(26)

Other joint ventures Total joint ventures Total associates

(1)

(1)

(15)

(27)

1

1

TOTAL

(14)

(26)

OPERATIONS HELD FOR SALE

Investments in joint ventures and associates

(in millions of euros)

December 31, 2016 December 31, 2015

Operations held for sale in 2015 AREVA NP

94

103

AREVA TA

- -

- -

Nuclear Measurements

Sub-total

94

103

Operations held for sale in 2016 NewCo

17 61 78

Adwen

Sub-total

TOTAL (*) * see note 3.

172

103

Share in negative net equity of joint ventures and associates

(in millions of euros)

December 31, 2016 December 31, 2015

Operations held for sale in 2015 New NP

- - - -

30

AREVA TA

- -

Nuclear Measurements

Sub-total

30

Operations held for sale in 2016 NewCo

63 63

TOTAL (*) * see note 3.

30

Enrichment Technology Company (ETC) is a joint venture held in equal shares by AREVA and Urenco. Its main activity is to build, assemble and install centrifuges and associated piping systems enabling its customers to enrich uranium. ETC is also involved in the design of ultracentrifugation enrichment plants to meet its customers’ needs and in project management for the construction of these facilities.

AREVA considers that it has an implicit obligation to ensure the continuity of ETC operations; consequently, and in accordance with the provisions of IAS 28, AREVA recognizes its share of negative equity under liabilities on its consolidated balance sheet and its share of negative net income on its statement of income and statement of consolidated comprehensive income.

222

2016 AREVA REFERENCE DOCUMENT